4//SEC Filing
REFSLAND EARL R 4
Accession 0001638599-21-000251
CIK 0000874710other
Filed
Feb 24, 7:00 PM ET
Accepted
Feb 25, 1:02 PM ET
Size
4.9 KB
Accession
0001638599-21-000251
Insider Transaction Report
Form 4
REFSLAND EARL R
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2021-02-24$5.52/sh−10,000$55,200→ 119,887 total
Footnotes (1)
- [F1]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.52 to $5.53 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
ALLIED HEALTHCARE PRODUCTS INC
CIK 0000874710
Entity typeother
Related Parties
1- filerCIK 0001160118
Filing Metadata
- Form type
- 4
- Filed
- Feb 24, 7:00 PM ET
- Accepted
- Feb 25, 1:02 PM ET
- Size
- 4.9 KB